Previously, survivin mRNA levels or cytoplasmic protein expression have been associated with poor outcome in various types of cancer, including breast cancer (16), lymphoma (17), non-small cell lung cancer (18), liver cancer (19), gastric carcinoma (20), ovarian carcinoma (24) and colorectal cancer (21–23). This evidence concerns the gene BIRC5 and gastric carcinoma.